NEW YORK, March 28, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Adeptus Health Inc. securities (NYSE:ADPT) from April 29, 2016 through March 1, 2017, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Adeptus investors under the federal securities laws.
To join the Adeptus class action, go to http://www.rosenlegal.com/cases-1066.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (1) Adeptus had material weaknesses in its internal control over financial reporting in the areas of revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures; and (2) as a result, defendants’ statements about Adeptus’ business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 9, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-1066.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Intel Stock Surges as AI Chip Demand Drives Strong Q2 Forecast
DeepSeek Launches V4 AI Models with Enhanced Reasoning and 1M Token Context Window
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
Samsung Boosts DRAM Supply to Tesla as AI-Driven Memory Demand Surges
European Car Sales Surge in March as EV and Hybrid Demand Accelerates
Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO
$16B Michigan Data Center Project Boosts U.S. AI Infrastructure Expansion
SpaceX President Gwynne Shotwell Earns $85.8M as IPO Buzz Grows
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift
U.S. Sanctions Target Chinese Refinery Over Iranian Oil Purchases
LG Innotek Stock Hits Record High on $68M Automotive Wi-Fi 7 Deal
Florida Launches Criminal Probe Into OpenAI Over FSU Shooting Incident
Kakaku.com Stock Surges on EQT Takeover Interest Amid Rising Japan Deal Activity
Amazon Stock Rises as Meta Expands AWS Partnership for AI Infrastructure
Nvidia Pushes 800V Data Center Power Systems to Boost Efficiency and Cut Costs
Why Global Web3 Projects Can't Afford to Skip South Korea: TokenPost Unveils Data-Driven Entry Solutions 



